{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-201733","form_type":"8-K","ticker":null,"cik":"0001183765","company_name":"Molecular Templates, Inc.","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.329757+00:00","generated_at":"2026-06-12T11:47:57.592322+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Molecular Templates announces C-suite reshuffle: interim CMO, President/CFO, COO, CSO","bullets":["Roger Waltzman resigns as CMO effective Aug 4, 2023; no disagreement cited.","Gabriela Gruia appointed interim CMO; $471,960 base salary, option for 175k shares.","Jason Kim named President and CFO, formalizing his interim CFO role.","Kristen Quigley named COO; Grace Kim named Chief Strategy Officer and Head of IR.","Board appoints Harold Selick to Audit Committee, Corsee Sanders to Nominating Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-201733","json":"https://secwatch.observer/filing/0001193125-23-201733.json","markdown":"https://secwatch.observer/filing/0001193125-23-201733.md","text":"https://secwatch.observer/filing/0001193125-23-201733.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1183765/000119312523201733/0001193125-23-201733-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1183765/000119312523201733/d483079d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T11:47:57.592322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c31a71110","claim":"Jason S. Kim was appointed as Chief Financial Officer at Molecular Templates, Inc..","evidence_excerpt":"On August 1, 2023, the Board also appointed Jason S. Kim, the Company’s Interim Chief Financial Officer, as its Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1183765/000119312523201733/0001193125-23-201733-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"2236a85550","claim":"Roger Waltzman resigned as Chief Medical Officer at Molecular Templates, Inc..","evidence_excerpt":"On July 27, 2023, Roger Waltzman, M.D. notified the Board of Directors (the “Board”) of Molecular Templates, Inc. (the “Company”) of his decision to resign from his position as Chief Medical Officer of the Company, effective as of August 4, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1183765/000119312523201733/0001193125-23-201733-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"},{"claim_id":"ca65246a49","claim":"Gabriela Gruia was appointed as Interim Chief Medical Officer at Molecular Templates, Inc..","evidence_excerpt":"On August 1, 2023, the Company appointed Gabriela Gruia, M.D. to serve as the Company’s interim Chief Medical Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1183765/000119312523201733/0001193125-23-201733-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}